View
141
Download
5
Category
Preview:
Citation preview
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Dosage Form Design: Pharmaceutical and Formulation Considerations
Chapter 4
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
ObjectivesObjectives
After reading this chapter, the student will be able to:
1. List reasons drugs are incorporated into various dosage forms.
2. Compare and contrast the advantages/disadvantages of various drug dosage forms.
3. Describe the information needed in preformulation studies to characterize a drug substance for possible inclusion into a dosage form.
4. Describe the mechanisms of drug degradation and provide examples of each.
5. Describe the five types of drug instability of concern to the practicing pharmacist.
6. Summarize approaches employed to stabilize drugs in pharmaceutical dosage forms.
7. Calculate rate reactions for various liquid dosage forms.
8. Categorize various pharmaceutical ingredients and excipients.
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Dosage Form Design: Pharmaceutical and Formulation ConsiderationsDosage Form Design: Pharmaceutical and Formulation Considerations
• The need for dosage forms
• General considerations in dosage form design
• Pharmaceutical ingredients and excipients
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
General Considerations in Dosage Form DesignGeneral Considerations in Dosage Form Design
• Preformulation Studies
– Physical Description
– Microscopic Examination
– Heat of Vaporization
– Melting Point Depression
– The Phase Rule
– Particle Size
– Polymorphism
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
General Considerations in Dosage Form Design (cont’d)General Considerations in Dosage Form Design (cont’d)
• Preformulation Studies (cont’d)
– Solubility
– Solubility and Particle Size
– Solubility and pH
– Dissolution
– Membrane Permeability
– Partition Coefficient
– pKa/Dissociation Constants
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
General Considerations in Dosage Form Design (cont’d)General Considerations in Dosage Form Design (cont’d)
• Drug and Drug Product Stability
– Drug Stability: Mechanisms of Degradation
– Drug and Drug Product Stability: Kinetics and Shelf Life
– Rate Reactions
– Q10 Method of Shelf Life Estimation
– Enhancing Stability of Drug Products
– Stability Testing
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Pharmaceutical Ingredients and ExcipientsPharmaceutical Ingredients and Excipients
• Definitions and Types
• Handbook of Pharmaceutical Excipients
• Harmonization of Standards
• Appearance and Palatability
– Flavoring Pharmaceuticals
– Sweetening Pharmaceuticals
– Coloring Pharmaceuticals
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Pharmaceutical Ingredients and Excipients (cont’d)Pharmaceutical Ingredients and Excipients (cont’d)
• Preservatives
– Sterilization and Preservation
– Preservative Selection
– General Preservative Considerations
– Mode of Action
– Preservative Utilization
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
The Need for Dosage Forms
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
The Need for Dosage FormsThe Need for Dosage Forms
• Mechanism for safe and convenient delivery of accurate dosage
• Protection of drug from atmosphere
• Protection of drug from gastric acid (EC)
• Conceal bitter, salty, or offensive taste or odor
• Provide liquid preparations of insoluble drugs
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
The Need for Dosage Forms (cont’d)The Need for Dosage Forms (cont’d)
• Provide clear liquid dosage forms (solutions)
• Provide rate-controlled drug action
• Provide topical drug action (ointments, creams, patches, ophthalmic, otic, nasal)
• Provide for insertion into body cavity
• Provide for placement into bloodstream
• Provide for inhalation therapy
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
General Considerations in Dosage Form Design
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Physiological States Altering Response to DrugsPhysiological States Altering Response to Drugs
• Age (infants)
• Age (elderly)
• Diurnal variation
• Pregnancy
• Sex
• Menopause
• Race
• Body weight
• Time of administration
• Tolerance
• Temperature
• Physiological reserve
• Milieu
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Factors Affecting Drug Presentation to the BodyFactors Affecting Drug Presentation to the Body
• Portal of drug entry into the body
• Physical form of the drug product
• Design and formulation of the product
• Method of manufacture of the product
• Physicochemical properties of the drug and excipients
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Factors Affecting Drug Presentation to the Body (cont’d)Factors Affecting Drug Presentation to the Body (cont’d)
• Physicochemical properties of the drug product
• Control and maintenance of location of drug at the absorption site
• Control of the release rate of the drug from the drug product
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Design of Drug ProductsDesign of Drug Products
• Effectiveness
• Safety
• Reliability
• Stability
– Physical
– Chemical
– Microbiological
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Design of Drug Products (cont’d)Design of Drug Products (cont’d)
• Pharmaceutical elegance
– Appearance
– Organoleptic properties
• Convenience
– Ease of use
– Dosing frequency
– Consumer acceptance
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
General Considerations in Dosage Form DesignGeneral Considerations in Dosage Form Design
• Preformulation Studies
• Drug and Drug Product Stability
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Preformulation StudiesPreformulation Studies
• Chemical characterization
• Physical characterization
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Physical DescriptionPhysical Description
• Solids, liquids, gases
• Chemical Properties
– Structure, form, reactivity
• Physical Properties
– Description, particle size, crystalline structure, melting point, solubility
• Biological Properties
– Ability to get to site of action and elicit a response
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Microscopic ExaminationMicroscopic Examination
• Particle size
• Particle size range
• Crystal structure
• Particle shape
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Heat of VaporizationHeat of Vaporization
• Vapor pressure
• Volatile drugs can migrate within a solid dosage form
• Personnel exposure
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Melting Point DepressionMelting Point Depression
• Purity determination
• Identity
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
The Phase RuleThe Phase Rule
• Phase diagrams
• Visual picture of presence of solid and liquid phases in binary, ternary, and other mixtures
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Particle SizeParticle Size
• Dissolution rate
• Bioavailability
• Content uniformity
• Taste
• Texture
• Color
• Stability
• Flow characteristics
• Sedimentation rates
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
PolymorphismPolymorphism
• Crystalline
• Amorphous
• Melting point variation
• Solubility differences
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
SolubilitySolubility
• Some aqueous solubility required for therapeutic efficacy
• Equilibrium solubility
• Solubility in different solvents
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Solubility and Particle SizeSolubility and Particle Size
• Small increases in solubility can be achieved by particle size reduction.
• Decreases in particle size may enhance dissolution rates.
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Solubility and pHSolubility and pH
• pH:solubility profiles are important.
• pH can affect solubility.
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
DissolutionDissolution
• Dissolution may be rate-limiting step in the absorption of poorly soluble drugs.
• Can affect onset, intensity, and duration of response and control overall bioavailability of the drug from the dosage form
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Membrane PermeabilityMembrane Permeability
• pKa, solubility, and dissolution rate data can provide an indication of absorption.
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Partition CoefficientPartition Coefficient
• Octanol:water partition coefficient often used in formulation development
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
pKa/Dissociation ConstantspKa/Dissociation Constants
• Extent of dissociation or ionization
• Dependent on pH of medium
• Can affect absorption, distribution, and elimination
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Drug and Drug Product StabilityDrug and Drug Product Stability
• Physical stability
• Chemical stability
• Shelf life of 2-3 years is generally desired
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Drug Stability: Mechanisms of DegradationDrug Stability: Mechanisms of Degradation
• Hydrolysis, solvolysis
• Oxidation
• Other processes
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Drug and Drug Product Stability: Kinetics and Shelf LifeDrug and Drug Product Stability: Kinetics and Shelf Life
• Chemical stability
• Physical stability
• Microbiological stability
• Therapeutic stability
• Toxicologic stability
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Rate ReactionsRate Reactions
• Change of drug concentration with respect to time
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Q10 Method of Shelf Life EstimationQ10 Method of Shelf Life Estimation
• Shelf life estimation
• Q10 = e{(Ea/R)[(1/T + 10) – (1/T)]}
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Enhancing Stability of Drug ProductsEnhancing Stability of Drug Products
• Excipients may be added to protect the drug
– Antioxidants
– Preservatives
– Chelating agents
– Buffering agents
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Stability TestingStability Testing
• Done at each stage of product development
• Product containers and closures must be considered
• Temperature and humidity studies
• Light studies
• Changes in physical appearance, color, odor, taste, texture
• Chemical changes of drug degradation
• Pharmacist is last professional to check for quality and stability prior to dispensing
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Kinetics and Drug Stability
Kinetics is important in all phases of the drug development process as well as in quality control,
stability, bioavailability, and therapeutic drug monitoring.
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
KineticsKinetics
• The study of the rate of chemical change and the way this rate is influenced by conditions of concentration of reactants, products, and other chemical species that may be present and by factors such as solvent, pressure, and temperature
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Importance of KineticsImportance of Kinetics
1. Selection of proper storage temperature
– Temperature
– Light
– Advising patient on storage conditions
2. Selection of proper container for dispensing
– Glass vs. plastic
– Clear vs. amber vs. opaque
– Cap liner selection
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Importance of Kinetics (cont’d)Importance of Kinetics (cont’d)
3. Anticipation of interactions when mixing drugs and dosage forms (incompatibilities)
– Active drugs
– Excipients
4. Dissolution determinations
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Importance of Kinetics (cont’d)Importance of Kinetics (cont’d)
5. ADME Processes in pharmacokinetics
– A = Absorption
– D = Distribution
– M = Metabolism/Biotransformation
– E = Excretion
6. Drug action at the molecular level
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Responsibility of the PharmacistResponsibility of the Pharmacist
• Dispense oldest stock first and observe expiration dates.
• Store products under conditions stated in USP monographs and/or labeling.
• Observe products for evidence of instability.
• Properly treat/label products that are repackaged, diluted, or mixed with other products.
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Responsibility of the Pharmacist (cont’d)Responsibility of the Pharmacist (cont’d)
• Dispensing in proper container with proper closure
• Informing/educating patients concerning proper storage and use of products, including the disposition of outdated or excessively aged prescriptions
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Why Do We Need Shelf Life Estimates?Why Do We Need Shelf Life Estimates?
• Expiration date given at room temperature:
– What is the expiration extension if refrigerated?
• Expiration date for refrig temperature given:
– How long if left at room temperature?
• Expiration date for room temperature given and it is desired to heat (autoclave):
– What is the % decomposition?
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Why Do We Need Shelf Life Estimates? (cont’d)Why Do We Need Shelf Life Estimates? (cont’d)
• Expiration date for refrigerated temperature given; product stored at room temperature and then returned to refrigerator:
– What is the new expiration date?
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Stability: USPStability: USP
• The extent to which a product retains, within specified limits, and throughout its period of storage and use (i.e., its shelf life), the same properties and characteristics that it possessed at the time of manufacture
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
DefinitionsDefinitions
• Accelerated Testing
– Studies designed to increase the rate of chemical or physical degradation by using exaggerated storage conditions
• Bulk Drug Substance
– Active drug before formulation
• Drug Product
– Finished dosage form
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Definitions (cont’d)Definitions (cont’d)
• Expiration Date
– The date placed on the immediate container label of a drug product that designates the date through which the product is expected to remain within specifications
• Expiration Dating Period
– The interval that a drug product is expected to remain within the approved specifications after manufacture
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Definitions (cont’d)Definitions (cont’d)
• Primary Stability Data
– Data on the drug product stored in the proposed container-closure for marketing under storage conditions that support the proposed expiration date
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Definitions (cont’d)Definitions (cont’d)
• Stability-Indicating Methodology
– Quantitative analytical methods based on the characteristic structural, chemical, or biological properties of each active ingredient of a drug product, and that will distinguish each active ingredient from its degradation products so that the active ingredient content can be accurately measured
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Definitions (cont’d)Definitions (cont’d)
• Stability
– The capacity of a drug product to remain within specifications established to ensure its identity, strength, quality, and purity
• Strength
– A quantitative measure of active ingredient, as well as other ingredients requiring quantitation
• Supportive Stability Data
– Data other than primary stability data
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Physical Paths of InstabilityPhysical Paths of Instability
• 1. Polymorphs
– Cocoa butter, Cortisone Acetate
• 2. Crystallization
– Solutions, suspensions
• 3. Vaporization
– Flavoring agents, cosolvents, nitroglycerin
• 4. Particle sedimentation
– Suspensions
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Observing Products for Evidence of InstabilityObserving Products for Evidence of Instability
• Solid Dosage Forms
– Hard/soft gelatin capsules
– Uncoated tablets
– Coated tablets
– Dry powders and granules
– Powders/granules for solution/suspension
– Effervescent tablets/granules/powders
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Observing Products for Evidence of Instability (cont’d)Observing Products for Evidence of Instability (cont’d)• Liquid Dosage Forms
– Solutions/elixirs/syrups
– Emulsions
– Suspensions
– Tinctures/fluid extracts
– Sterile liquids
• Semisolids
– Creams
– Ointments
– Suppositories
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Reaction KineticsReaction Kinetics
• Want two things from kinetic data:
– Reaction order
– Reaction rate
• In considering the chemical stability of a pharmaceutical, we need to know the REACTION ORDER, which is obtained experimentally by measuring the REACTION RATE as a function of concentration of the degrading drug.
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Reaction KineticsReaction Kinetics
• The overall ORDER of a reaction is the SUM of the EXPONENTS of the CONCENTRATION terms of the RATE EXPRESSION.
• The ORDER with respect to EACH REACTANT is the EXPONENT of the INDIVIDUAL CONCENTRATION terms in the RATE EXPRESSION.
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Order of a ReactionOrder of a Reaction
• An experimental quantity; merely provides information about the way in which the rate depends on concentration
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Factors Affecting Reaction RatesFactors Affecting Reaction Rates
• Temperature
• Dielectric Constant
• Ionic Strength
• Solvent Effect
• Catalysis
• Light
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Chemical Kinetics vs. Chemical StabilityChemical Kinetics vs. Chemical Stability
• KINETICS
• Several half-lives
• Pure systems
• Goal is to elucidate reaction mechanisms.
• STABILITY
• Down to about 85% of drug remaining
• Involves complete dosage form
• Goal is to establish an expiration date.
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
First-Order Rate ReactionFirst-Order Rate Reaction
–dt
dC= kC
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Half-LifeHalf-Life
• Is meaningless to attempt to describe the time required for ALL material to decompose (i.e., infinity)
• Therefore, reaction rate can be described by K or half-life, t1/2
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Zero-Order Rate ReactionZero-Order Rate Reaction
–dC\dt = k0
C = –k0t + C0
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Arrhenius EquationArrhenius Equation
log = k2\k1 = Ea (t2 – T1)\2.3 RT1T2
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Arrhenius Equation (cont’d)Arrhenius Equation (cont’d)
• Energy of activation calculations
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Energy of Activation and Reaction TypesEnergy of Activation and Reaction Types
• 2-3 kcal/mole----------
• <10 kcal/mole---------
• 10-30 kcal/mole-------
• 50-70 kcal/mole-------
• Diffusion or photolysis
• Fast reactions stability problems in development
• Solvolytic process; most drug degradation
• Pyrolytic reactions
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Shelf Life EstimatesShelf Life Estimates
• Q10 = [K(T+10)]/KT
• =e[-(Ea/R) ({1/T+10} - {1/T}]
• Q10 =2 Lower limit
• Q10 = 3 Average, best estimate
• Q10 = 4 Upper limit
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
t90 Equation for Shelf Life Estimatest90 Equation for Shelf Life Estimates
• t90(T2) = t90(T1)/Q10(Delta T/10)
• Note: A “+” Delta T decreases shelf life and a “-” Delta T increases shelf life
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Pharmaceutical Ingredients and Excipients
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Definitions and TypesDefinitions and Types
• Active pharmaceutical ingredients
• Pharmaceutical ingredients added to prepare a dosage form
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Components of Drug Delivery SystemsComponents of Drug Delivery Systems
• Drug
• Route of administration
• Suitable physical dosage form
• Use of chemical derivatives of the drug
• Control of certain physicochemical and/or biochemical processes that alter the rate and extent of response
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
ExcipientsExcipients
• Coloring agents
• Sweetening agents
• Flavoring agents
• Surfactants
• Solubilizing agents
• Antioxidants
• Preservatives
• Thickening agents
• Suspending agents
• Binding agents
• Solvents
• Lubricants
• Perfumes
• Fats and oils
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Handbook of Pharmaceutical ExcipientsHandbook of Pharmaceutical Excipients
• Monographs on more than 250 excipients used in dosage form preparation
• Additional excipients listed in Food Chemicals Codex and National Formulary
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Harmonization of StandardsHarmonization of Standards
• International harmonization of excipients
• Pharmaceutical industry is multinational
• Uniform standards needed
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Appearance and PalatabilityAppearance and Palatability
• Compliance issues
• Odor, color, and taste
• Important for all age groups, especially pediatrics and geriatrics
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Flavoring PharmaceuticalsFlavoring Pharmaceuticals
• Complex area
• Important for compliance
• Color and taste should generally match
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
FlavorFlavor
• Taste
• Touch
• Smell
• Sight
• Sound
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Four Primary TastesFour Primary Tastes
• Sweet
• Bitter
• Sour
• Salty
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Four Primary Tastes (cont’d)Four Primary Tastes (cont’d)
• TASTE SLIGHT MOD STRG
• Sweet/Sucrose 5% 10% 15%
• Sour/Citric Acid 0.05 0.10 0.20
• Salty/NaCl 0.4 0.7 1.0
• Bitter/Caffeine 0.05 0.10 0.20
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Causative Factors for TasteCausative Factors for Taste
• Hot Mild, counterirritant
• Astringent Tannins, acids
• Coarseness/Grittiness Texture
• Coolness Neg heat of solution
• Greater sensitivity to odors than to tastes
• Females have greater sensitivity to odors than males
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Flavor/Odor Correlations with Chemical StructureFlavor/Odor Correlations with Chemical Structure
• Sour taste H+
• Saltiness Anions & cations
• Bitter High-MW salts
• Sweet Polyhydroxyl cmpds, polyhalogenated cmpds,
alpha amino acids
• Sharp, biting Unsaturation
• Camphoraceous odor Tertiary “C” atom
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Flavor/Odor Correlations with Chemical Structure (cont’d)Flavor/Odor Correlations with Chemical Structure (cont’d)
• Pleasant odor Ketones
• Methylparaben Floral, gauze-pad
• Propyl/butyl paraben Numbing mouthfeel
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Flavor SelectionFlavor Selection
• Immediate flavor identity
• Rapid full flavor development
• Acceptable mouthfeel
• Short aftertaste
• No undesirable sensations
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Flavoring TechniquesFlavoring Techniques
• Blending
– Fruit===========Sour
– Salty/Sweet/Sour===Bitter
– Salty===========Decreases sourness
– Salty===========Increases sweetness
• Overshadowing
– Methylsalicylate====Glycyrrhiza
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Flavoring Techniques (cont’d)Flavoring Techniques (cont’d)
• Physical
– Formation of insoluble compounds
– Emulsification of oils
– Effervescence
– High-viscosity fluids
– Coating tablets
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Flavoring Techniques (cont’d)Flavoring Techniques (cont’d)
• Chemical
– Adsorption-silica gel
– Complexation
• Physiological
– Anesthetic effect====Menthol (mint)
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Raspberry Concentrate ImitationRaspberry Concentrate Imitation
• Vanillin 0.180 g
• Indol 0.004 g
• Aldehyde C16 0.240 mL
• Diacetyl 0.060 mL
• Phenylethyl alcohol 240 mL
• Aldehyde C14 0.015 mL
• Aldehyde C18 0.015 mL
• Aldehyde C20 0.400 mL
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Raspberry Concentrate Imitation (cont’d)Raspberry Concentrate Imitation (cont’d)
• Orange flower oil 0.005 mL
• Ethyl butyrate 0.120 mL
• Benzyl acetate 0.075 mL
• Alpha novoviol 0.400 mL
• Beta novoviol 0.200 mL
• Lemon oil 0.060 mL
• Propylene glycol qs100 mL
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Flavor Selection GuideFlavor Selection Guide
• Salty Butterscotch/Maple
• Bitter Wild Cherry/Licorice
Chocolate Mint
• Acrid/Sour Raspberry/Fruit
Berry/Acacia Syrup
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Flavor Selection Guide (cont’d)Flavor Selection Guide (cont’d)
• Oily Peppermint/Anise
Wintergreen
• Sweet Fruit/Berry/Vanilla
• Acid Citrus
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Sweetening PharmaceuticalsSweetening Pharmaceuticals
• Complex area
• Natural vs. synthetic
• Heat stability
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Sweetening AgentsSweetening Agents
• Dextrose
• Mannitol
• Saccharin
• Sorbitol
• Sucrose
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Coloring PharmaceuticalsColoring Pharmaceuticals
• Lighter shades preferred
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Coloring AgentsColoring Agents
• Dyes: FD&C, D&C, Ext D&C
• Lakes: Calcium and aluminum salts
• Liquids: 0.001% to 0.0005%
• Powders: 0.1%
• Caramel
• Ferric oxide: Red/yellow
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Coloring Agents (cont’d)Coloring Agents (cont’d)
• Red No. 1, Ponceau 3R, Cherry Red
– 9.8/5
• Blue No. 1, Brilliant Blue, Blue-Green
– 20/20
• Yellow No. 5, Tartrazine, Lemon Yellow
– 20/18
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
PreservativesPreservatives
• Sterilization and Preservation
• Preservative Selection
• General Preservative Considerations
• Mode of Action
• Preservative Utilization
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Sterilization and PreservationSterilization and Preservation
• Some products must be sterile
– Injectables
– Ophthalmics
• Sterilization
– Autoclave
– Filtration
– Dry heat
– Irradiation
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Preservative SelectionPreservative Selection
• Dosage form
• Route of administration
• Compatibility with excipients
• Container and closure compatibility
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
General Preservative ConsiderationsGeneral Preservative Considerations
• Range of activity
• Concentration required
• pH requirements
• Compatibility
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Mode of ActionMode of Action
• Modification of cell membrane permeability
• Lysis and cytoplasmic leakage
• Irreversible coagulation of cytoplasmic constituents
• Inhibition of cellular metabolism
• Oxidation of cellular constituents
• Hydrolysis
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
Preservative UtilizationPreservative Utilization
• Benzoic acid/sodium benzoate
• Alcohol
• Phenylmercuric nitrate/acetate
• Phenol
• Cresol
• Chlorobutanol
• Benzalkonium chloride
• Methylparaben/propylparaben
• Others
Recommended